Expanded FDA regulation of health and wellness apps
This paper argues that the Food and Drug Administration’s (FDA) policy for health and wellness apps is ethically problematic. Currently, the FDA does not regulate health and wellness apps that are not intended for medical use. As a result of this hands-off policy, preventing harm to consumers is lef...
| VerfasserInnen: | ; |
|---|---|
| Medienart: | Elektronisch Aufsatz |
| Sprache: | Englisch |
| Verfügbarkeit prüfen: | HBZ Gateway |
| Journals Online & Print: | Lade...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Veröffentlicht: |
Wiley-Blackwell
[2020]
|
| In: |
Bioethics
Jahr: 2020, Band: 34, Heft: 3, Seiten: 235-241 |
| RelBib Classification: | KBQ Nordamerika NCH Medizinische Ethik ZC Politik ZG Medienwissenschaft; Digitalität; Kommunikationswissenschaft |
| weitere Schlagwörter: | B
FDA
B Public Health B medical devices B mobile health B health apps |
| Online Zugang: |
Volltext (Verlag) Volltext (doi) |
| Zusammenfassung: | This paper argues that the Food and Drug Administration’s (FDA) policy for health and wellness apps is ethically problematic. Currently, the FDA does not regulate health and wellness apps that are not intended for medical use. As a result of this hands-off policy, preventing harm to consumers is left primarily to developers and app marketplaces. We argue that the FDA’s duties to prevent harm and maintain accountability to the American public require that they play a much stronger role. We also discuss concerns about efficiency and fostering innovation, and argue that while they should help shape FDA regulation of health and wellness apps, they do not justify complete absence of FDA involvement. |
|---|---|
| ISSN: | 1467-8519 |
| Enthält: | Enthalten in: Bioethics
|
| Persistent identifiers: | DOI: 10.1111/bioe.12674 |